Cargando…
A Case of Coronavirus Disease 2019 Treated With Ciclesonide
Autores principales: | Nakajima, Kento, Ogawa, Fumihiro, Sakai, Kazuya, Uchiyama, Munehito, Oyama, Yutaro, Kato, Hideaki, Takeuchi, Ichiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mayo Foundation for Medical Education and Research
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7158774/ https://www.ncbi.nlm.nih.gov/pubmed/32402512 http://dx.doi.org/10.1016/j.mayocp.2020.04.007 |
Ejemplares similares
-
Environmental maintenance with effective and useful zoning to protect patients and medical staff from COVID‐19 infection
por: Ogawa, Fumihiro, et al.
Publicado: (2020) -
A Case of Central Pontine Myelinolysis Occurred During Treatment of Hyperosmolar Hyperglycemic Syndrome
por: Niida, Shoko, et al.
Publicado: (2021) -
Serum cholinesterase associated with COVID-19 pneumonia severity and mortality
por: Nakajima, Kento, et al.
Publicado: (2021) -
A randomized, double-blind study comparing the efficacy and safety of a combination of formoterol and ciclesonide with ciclesonide alone in asthma subjects with moderate-to-severe airflow limitation
por: Barthwal, Madhu Sudan, et al.
Publicado: (2017) -
Ciclesonide as a manic trigger in a patient with long-term stable bipolar disorder: a case report
por: Vilela, Bárbara F.C., et al.
Publicado: (2020)